Regis CorpRGS
Price$29.43Intrinsic value$28.015% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $224.5M+6.8% YoYTTM through 31 Mar 2026
Net Income $6.9M-94.4% YoYTTM through 31 Mar 2026
Free Cash Flow $11.1MTTM through 30 Jun 2026

Margins

Current
EBITDA Margin12.6%
Operating Margin10.9%
Net Margin3.1%

Returns

62.8%ROE
21.4%ROA
2.4%ROIC

Balance Sheet Health

Debt / Equity0.61x
Current Ratio0.59x
Net Debt$104.2M
Cash & Equivalents$26M

Quality Metrics

Altman Z-Score0.88
Piotroski F-Score6 / 9
FCF Margin5.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25'26
FY2026: $224.5M
Diluted EPS$2.41TTM
'20'21'22'23'24'25'26
FY2026: $2.41

Dividend

No dividend

Capital Allocation

Capex Intensity0.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.